Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.90 Insider Own2.79% Shs Outstand69.01M Perf Week-10.00%
Market Cap124.22M Forward P/E- EPS next Y-0.76 Insider Trans0.70% Shs Float67.09M Perf Month12.85%
Income-53.93M PEG- EPS next Q-0.23 Inst Own60.52% Short Float0.95% Perf Quarter-7.22%
Sales0.59M P/S210.54 EPS this Y2.39% Inst Trans0.60% Short Ratio1.11 Perf Half Y53.85%
Book/sh1.24 P/B1.46 EPS next Y16.89% ROA-43.13% Short Interest0.64M Perf Year-26.98%
Cash/sh1.22 P/C1.47 EPS next 5Y13.00% ROE-55.50% 52W Range1.08 - 2.53 Perf YTD27.66%
Dividend Est.- P/FCF- EPS past 5Y43.36% ROI-55.34% 52W High-28.85% Beta1.20
Dividend TTM- Quick Ratio6.07 Sales past 5Y436.18% Gross Margin-368.71% 52W Low66.65% ATR (14)0.10
Dividend Ex-Date- Current Ratio6.07 EPS Y/Y TTM37.64% Oper. Margin-9994.56% RSI (14)50.93 Volatility5.81% 4.96%
Employees59 Debt/Eq0.17 Sales Y/Y TTM-94.34% Profit Margin-9171.60% Recom1.00 Target Price25.25
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q17.81% Payout- Rel Volume0.20 Prev Close1.80
Sales Surprise540.33% EPS Surprise8.00% Sales Q/Q- EarningsMay 02 AMC Avg Volume572.08K Price1.80
SMA202.73% SMA501.00% SMA20012.67% Trades Volume113,697 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jul-05-23Downgrade Oppenheimer Outperform → Perform
Oct-12-21Initiated RBC Capital Mkts Outperform $22
Sep-21-21Initiated Piper Sandler Overweight $19
May-10-21Initiated Laidlaw Buy $18
Aug-17-20Upgrade H.C. Wainwright Neutral → Buy $13
Mar-04-20Initiated ROTH Capital Buy $15
Mar-02-20Initiated Oppenheimer Outperform $8
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Sep-07-17Initiated Piper Jaffray Overweight $7
Dec-13-16Downgrade JP Morgan Overweight → Neutral
May-24-24 04:00PM
May-15-24 07:00AM
May-14-24 08:00AM
May-06-24 08:00AM
May-02-24 09:58PM
04:15PM Loading…
Apr-01-24 08:00AM
Mar-26-24 02:19PM
Mar-15-24 01:33PM
Mar-14-24 08:56PM
08:00AM Loading…
Feb-28-24 08:00AM
Feb-21-24 08:00AM
Jan-29-24 08:00AM
Jan-18-24 08:00AM
Nov-13-23 08:00AM
Nov-09-23 04:07PM
Nov-01-23 08:00AM
Oct-31-23 08:00AM
Sep-11-23 08:00AM
Aug-30-23 09:35AM
Aug-24-23 08:00AM
Aug-09-23 05:30PM
07:30AM Loading…
Jul-20-23 07:30AM
Jun-28-23 07:00AM
Jun-22-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 04:00PM
Jun-06-23 08:00AM
May-25-23 08:00AM
May-22-23 08:00AM
May-13-23 08:06AM
May-11-23 04:00PM
May-10-23 06:11AM
May-09-23 05:15PM
May-07-23 04:00AM
May-05-23 02:24PM
Apr-17-23 08:00AM
Mar-30-23 08:00AM
Mar-28-23 10:45AM
Mar-23-23 07:10AM
Mar-21-23 08:00AM
Mar-20-23 08:00AM
Mar-09-23 05:15PM
Mar-08-23 08:00AM
Mar-02-23 08:00AM
Mar-01-23 08:00AM
Feb-17-23 12:00PM
Feb-10-23 05:21AM
Feb-09-23 08:00AM
Feb-08-23 04:11PM
Feb-06-23 08:00AM
Jan-31-23 08:00AM
Jan-19-23 08:00AM
Jan-18-23 08:00AM
Dec-29-22 06:59PM
Dec-15-22 08:00AM
Nov-18-22 04:00PM
Nov-10-22 05:15PM
Nov-09-22 08:00AM
Nov-03-22 08:02AM
Oct-25-22 08:00AM
Oct-11-22 08:00AM
Oct-04-22 08:00AM
Sep-29-22 08:00AM
Sep-27-22 08:00AM
Sep-16-22 08:35AM
Sep-13-22 08:00AM
Sep-12-22 08:35AM
Sep-09-22 11:52AM
Sep-06-22 08:00AM
Sep-01-22 08:00AM
Aug-15-22 04:00PM
Aug-12-22 04:05PM
Aug-11-22 08:03AM
Aug-04-22 08:00AM
Jun-24-22 02:22PM
Jun-14-22 08:00AM
Jun-13-22 08:00AM
Jun-01-22 08:00AM
May-17-22 08:00AM
May-16-22 08:00AM
May-13-22 04:00PM
May-10-22 02:00PM
May-09-22 05:15PM
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadfoot Jill MarieChief Financial OfficerFeb 06 '24Sale1.691,5902,68720,821Feb 06 08:18 PM
Shukla SanjayPresident and CEODec 12 '23Buy1.1812,00014,136106,173Dec 12 06:50 PM
Shukla SanjayPresident and CEODec 11 '23Buy1.173,0003,51094,173Dec 12 06:50 PM
Shukla SanjayPresident and CEONov 13 '23Buy1.1113,57815,08591,173Nov 13 04:11 PM
Shukla SanjayPresident and CEONov 10 '23Buy1.141,4221,61877,595Nov 13 04:11 PM
Shukla SanjayPresident and CEOJul 28 '23Buy2.0115,00030,22476,173Aug 01 04:07 PM